Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 51: 1365-1373, 2005. First published June 10, 2005; 10.1373/clinchem.2004.045088
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplements
Right arrow All Versions of this Article:
clinchem.2004.045088v1
51/8/1365    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chmielewicz, B.
Right arrow Articles by Ellerbrok, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chmielewicz, B.
Right arrow Articles by Ellerbrok, H.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2005;51:1365-1373.)
© 2005 American Association for Clinical Chemistry, Inc.

Molecular Diagnostics and Genetics

Development of a PCR-Based Assay for Detection, Quantification, and Genotyping of Human Adenoviruses

Barbara Chmielewicz1,a, Andreas Nitsche2, Brunhilde Schweiger3 and Heinz Ellerbrok2

Robert Koch-Institut,1 Projektgruppe, Neuartige Viren’, 2 Zentrum für Biologische Sicherheit 1, and 3 FG12 ‘Virale Infektionen’, Berlin, Germany.

aAddress correspondence to this author at: Robert Koch-Institut, Projektgruppe P11, Nordufer 20, 13353 Berlin, Germany. Fax 49-30-4547-2605; e-mail chmielewiczb{at}rki.de.

Background: Adenoviruses (AdVs) can cause serious disease in immunosuppressed patients, particularly those undergoing allogeneic stem cell transplantation. A method for virus quantification in clinical specimens is essential for monitoring patient adenoviral loads and evaluating new therapeutic approaches.

Methods: We developed a PCR-based assay that combines detection and genotyping of human AdVs, targeting a highly conserved region of the adenoviral genome coding for the DNA polymerase (AdV DPol PCR). We tested the diagnostic applicability of this PCR-based assay by analyzing 159 clinical specimens from children with respiratory disease and comparing the results with those obtained by nested PCR analysis.

Results: The PCR assay detected all currently known AdV serotypes, with a detection limit of ~10 genome equivalents per reaction for 49 of 51 serotypes. No cross-reactivity to human DNA or other DNA viruses was observed. In addition, genotyping of PCR-positive samples was achieved within minutes by fluorescence curve melting analysis in a LightCycler instrument using 6 pairs of hybridization probes, each specific for a single AdV species. Results for clinical specimens were in good concordance with those obtained by nested PCR.

Conclusion: The presented assay is a suitable tool for the detection and genotyping of human AdVs in clinical samples.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.